Haleon (Haleon) Construction In Progress : $0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Construction In Progress?

Haleon's quarterly construction in progress increased from Sep. 2023 ($0 Mil) to Dec. 2023 ($472 Mil) but then declined from Dec. 2023 ($472 Mil) to Mar. 2024 ($0 Mil).

Haleon's annual construction in progress increased from Dec. 2021 ($398 Mil) to Dec. 2022 ($474 Mil) but then declined from Dec. 2022 ($474 Mil) to Dec. 2023 ($472 Mil).

Haleon Construction In Progress Historical Data

The historical data trend for Haleon's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Construction In Progress Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

275.23

373.66

397.61

473.81

472.15

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial									-	-	-	472.15	-

Haleon Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Haleon (Haleon) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN1:Mexico HLNl:UK HLN:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.